The study is part of the Biomarkers Consortium, and will include the collection of DNA samples for future genomics research into ASD.
Advances in genetic technologies are paving the way to elucidate the pathophysiology of autism, according to an article in Lancet Neurology.
A $4.6 million Simons Foundation grant will fund enrollment and initial data collection, but additional resources are necessary for genetic analysis and hypothesis generation.
Harvard Medical School's Kaitlin Samocha is studying de novo mutations linked to complex diseases like autism and schizophrenia.
With $4.6M in funding from the Simons Foundation, Kaiser will collect data from 5,000 families in Northern California.
David Glazer from Google Genomics provided an update on the MSSNG project, a collaboration between Autism Speaks, The Hospital for Sick Children in Toronto, and Google.
By focusing on girls with severe autism, Johns Hopkins researchers uncovered four candidate genes for the disorder, including one involved in neuronal development and chromatin biology.
Researchers uncover possible salivary protein markers for autism.
The company raised about $12.2 million in a second tranche of the Series C round, which will be used to increase adoption of its ASD diagnostic tests.
Genoma will commercialize the Arisk test outside the US and will provide genetic consulting services and diagnostics services to children with ASD and their parents.
The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.
The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.
A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.
In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.